Abivax (ABVX) Long-Term Debt Repayments (2024 - 2025)
Abivax's (ABVX) quarterly Long-Term Debt Repayments came in at -$14.5 million in Q3 2025, down 501.48% year-on-year from $3.6 million in Q3 2024, and down 941.67% quarter-over-quarter from $1.7 million in Q2 2025.
Abivax (ABVX) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends
Abivax's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at -$14.5 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.64 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -14.45 Mn |
| Sep 30, 2025 | -14.45 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -3.90 Mn |
| Mar 31, 2025 | -3.90 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.36 Mn |
| Mar 31, 2024 | -2.38 Mn |
| Mar 31, 2024 | -2.38 Mn |